Clinical Trials In Charlotte
Discover hundreds of clinical trials in Charlotte.
Search clinical trials in Charlotte by condition or phase.
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Sponsor:
Janssen Research & Development, LLC
Location:
Code:
NCT05754957
Conditions
Acute Coronary Syndrome
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Milvexian
Placebo
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT03871257
Conditions
Low Grade Glioma
Neurofibromatosis Type 1
Visual Pathway Glioma
Eligibility Criteria
Sex: All
Age: 2 - 21
Healthy Volunteers: Not accepted
Interventions
Carboplatin
Magnetic Resonance Imaging
Quality-of-Life Assessment
Questionnaire Administration
Selumetinib Sulfate
A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma
Sponsor:
Jiangsu Simcere Pharmaceutical Co., Ltd.
Location:
Code:
NCT05569057
Conditions
Advanced Solid Tumor
Cutaneous T-cell Lymphoma (CTCL)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
SIM1811-03
A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma
Sponsor:
GlaxoSmithKline
Location:
Code:
NCT06261957
Conditions
Asthma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Salbutamol HFA-134a
Salbutamol HFA-152a
Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab
Sponsor:
Genmab
Location:
Code:
NCT05206357
Conditions
Non-hodgkin Lymphoma
Eligibility Criteria
Sex: All
Age: 1 - 25
Healthy Volunteers: Not accepted
Interventions
Epcoritamab
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
Sponsor:
AbbVie
Location:
Code:
NCT05609630
Conditions
Juvenile Idiopathic Arthritis
Eligibility Criteria
Sex: All
Age: 1 - 17
Healthy Volunteers: Not accepted
Interventions
Upadacitinib
Tocilizumab
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Sponsor:
SWOG Cancer Research Network
Location:
Code:
NCT03678025
Conditions
Castration Levels of Testosterone
Metastatic Prostatic Adenocarcinoma
Stage IV Prostate Cancer AJCC v8
Stage IVA Prostate Cancer AJCC v8
Stage IVB Prostate Cancer AJCC v8
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Abiraterone
Bicalutamide
Degarelix
Docetaxel
Flutamide
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Sponsor:
Astellas Pharma Global Development, Inc.
Location:
Code:
NCT02960022
Conditions
Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
enzalutamide
abiraterone acetate
prednisone
PRO1160 for Advanced Solid and Liquid Tumors (PRO1160-001)
Sponsor:
ProfoundBio US Co.
Location:
Code:
NCT05721222
Conditions
Renal Cell Carcinoma
Nasopharyngeal Carcinoma
Non Hodgkin Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PRO1160